| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/25/2006 | US7033813 Deactivation vaccine; using critical temperature, critical pressure solvent |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033799 Haemophilus adherence and penetration proteins |
| 04/25/2006 | US7033798 Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment |
| 04/25/2006 | US7033796 cloned from cDNA library of human liver carcinoma cell line using PCR amplification; host cells |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033774 Comprises immunoglobulin for detection of drugs and/or natural peptide hormones used for enhancing athletic performance and in humans and animals |
| 04/25/2006 | US7033771 contacting composition of insulin-responsive aminopeptidase (IRAP) and human trancytosis-associated protein (TAP) with a test compound and determining binding; glucose transporter proteins; vesicle transport proteins |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033752 Spinal muscular atrophy diagnostic methods |
| 04/25/2006 | US7033748 Detection of prefrential microorganisms in sample, obtain cells, culture, propagate detect expression of bacterial prteins, the presence of bacterial protein indnicates infection |
| 04/25/2006 | US7033593 Immunogen comprising an HIV envelope protein, a ligand and H2 peptide |
| 04/25/2006 | US7033590 Factor IX/factor IXa activating antibodies and antibody derivatives |
| 04/25/2006 | US7033589 γ-1 anti-human CD23 monoclonal antibodies and use thereof as therapeutics |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | CA2353520C Animal model for psoriasis for the prevention and treatment of psoriasis in humans |
| 04/25/2006 | CA2215528C Method for diagnosing a patient for chlamydia |
| 04/20/2006 | WO2006042158A2 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | WO2006041970A2 Treatment of respiratory syncytial virus (rsv) infection |
| 04/20/2006 | WO2006041934A2 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | WO2006041280A1 Novel regulation protein |
| 04/20/2006 | WO2006041211A1 Protein capable of binding to plasticizer |
| 04/20/2006 | WO2006040764A2 System and method for production of antibodies in plant cell culture |
| 04/20/2006 | WO2006040163A1 Monoclonal antibody against frizzled receptors |
| 04/20/2006 | WO2006014903A3 Compositions and methods of use for adam12 antagonists in treating disease |
| 04/20/2006 | WO2006012500A3 Crystallization of antibodies or fragments thereof |
| 04/20/2006 | WO2005112969A3 Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
| 04/20/2006 | WO2005111077A3 Methods for treating bone cancer pain by administering a nerve growth factor antagonist |
| 04/20/2006 | WO2005105841A3 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 04/20/2006 | WO2005097185A3 Irta-5 antibodies and their uses |
| 04/20/2006 | WO2005097183A3 Treatment of diseases |
| 04/20/2006 | WO2005092378A3 Anti-vglut glutamate transporter antibodies for use in pain therapy |
| 04/20/2006 | WO2005089315A3 Methods and compositions related to skcg-1, a tumor suppressor gene |
| 04/20/2006 | WO2005084109A3 Cancer specific gene mh15 |
| 04/20/2006 | WO2003047514A3 Reducing myelin-mediated inhibition of axon regeneration |
| 04/20/2006 | US20060084600 Human homologues of fused gene |
| 04/20/2006 | US20060084593 Anti-hiv composition, production method thereof and medicament |
| 04/20/2006 | US20060084164 Bacteria, yeasts or filamentous fungi, producing a fusion protein containing a hydrophobin fused to a protein, an enzyme or part of an enzyme with enzymatic activity, wherein said hydrophobin or hydrophobin-like protein has an ability to partition in aqueous two-phase systems (ATPS) |
| 04/20/2006 | US20060084148 April-a novel protein with growth effects |
| 04/20/2006 | US20060084145 sRAGE mimetibody, compositions, methods and uses |
| 04/20/2006 | US20060084144 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084143 Screen for agonists and antagonists; treat solid tumors, vascular deficiencies; polypeptide, polynucleotide, plasmid; chemotherapeutic agents, alkylating agents, antimetabolites, vinca alkaloids, plant extracts, nitrosoureas, topoisomerase inhibitors, platinum analogs, adrenocortical suppressants |
| 04/20/2006 | US20060084139 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084138 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide |
| 04/20/2006 | US20060084124 Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors |
| 04/20/2006 | US20060084122 Method of judging leukemia, pre-leukemia or aleukemic malignant blood disease and diagnostic therefor |
| 04/20/2006 | US20060084121 OX2 receptor homologs |
| 04/20/2006 | US20060084120 Identifying inhibitor of hepsin using polypeptide; modulate signaling pathway; use in treatment of cancer |
| 04/20/2006 | US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus |
| 04/20/2006 | US20060084117 Galphaq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors |
| 04/20/2006 | US20060084112 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states |
| 04/20/2006 | US20060084107 Methods of treating skin conditions using inhibitors of the CD2/LFA-3 interaction |
| 04/20/2006 | US20060084091 Methods and compositions for polypeptide engineering |
| 04/20/2006 | US20060084084 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/20/2006 | US20060084055 Compositions and methods for the detection diagnosis and therapy of hematological malignancies |
| 04/20/2006 | US20060083752 Novel compounds |
| 04/20/2006 | US20060083747 Fc fusion |
| 04/20/2006 | US20060083745 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 04/20/2006 | US20060083743 Method of cancer therapy by in situ production of F5 antibodies |
| 04/20/2006 | US20060083741 Treatment of respiratory syncytial virus (RSV) infection |
| 04/20/2006 | US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies |
| 04/20/2006 | US20060083739 Treating prostate cancer with anti-ErbB2 antibodies |
| 04/20/2006 | US20060083738 Treatment of cancer by the use of anti fas antibody |
| 04/20/2006 | US20060083735 Antigen-presenting complex-binding compositions and uses thereof |
| 04/20/2006 | US20060083716 Composition for delivering an agent to a target cell and uses thereof |
| 04/20/2006 | US20060083713 Methods of using a human il-17 related polypeptide to treat disease |
| 04/20/2006 | US20060083686 Therapeutic agent for ulcerative colitis |
| 04/20/2006 | US20060083683 Cysteine residue within the hinge region of the antibody fragment; a disulfide bridge within the hinge region is avoided by substituting another amino acid for the corresponding cysteine residue in the opposite chain of the fragment; conjugate binds the same antigen as the unmodified parental molecule |
| 04/20/2006 | DE102004050620A1 Monoklonaler Antikörper gegen Frizzled-Rezeptoren Monoclonal antibodies against Frizzled receptors |
| 04/20/2006 | DE102004050101A1 Recombined polypeptide antibody or antibody fragment binds the ED-B domain of Fibronectin |
| 04/20/2006 | CA2583691A1 System and method for production of antibodies in plant cell culture |
| 04/20/2006 | CA2583017A1 Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease |
| 04/20/2006 | CA2582919A1 Immunotherapy of autoimmune disorders |
| 04/20/2006 | CA2582194A1 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | CA2582157A1 Methods and compositions for improving recombinant protein production |
| 04/20/2006 | CA2580271A1 Method for treating vasculitis |
| 04/20/2006 | CA2579161A1 Novel regulation protein |
| 04/20/2006 | CA2577598A1 Modulators of hepatocyte growth factor activator |
| 04/19/2006 | EP1647596A2 Monoclonal antibody against platelet membrane glycoprotein vi |
| 04/19/2006 | EP1646869A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/19/2006 | EP1646856A2 Methods for identifying compounds for regulating muscle mass or function using dopamine receptors |
| 04/19/2006 | EP1646720A2 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 04/19/2006 | EP1646657A1 Antibodies to cd44 vra and methods of use |
| 04/19/2006 | EP1646656A2 Human antibody molecules for il-13 |
| 04/19/2006 | EP1646655A2 Tgf-beta1 ligands |
| 04/19/2006 | EP1646654A1 BINDING MEMBER TOWARDS PNEUMOCOCCUS SURFACE ADHESIN A PROTEIN (PsaA) |
| 04/19/2006 | EP1646652A2 Methods for for modeling gpcrs and for producing ligand blocking and receptor activating antibodies for same |
| 04/19/2006 | EP1646647A1 Babesia vaccines |
| 04/19/2006 | EP1646402A2 Antibodies to the fbsa protein of streptococcus agalactiae and their use in treating or preventing infections |
| 04/19/2006 | EP1646401A2 Specific human antibodies |
| 04/19/2006 | EP1646357A2 Pro104 antibody compositions and methods of use |
| 04/19/2006 | EP1646282A1 Genetic vaccines for cancer therapy |
| 04/19/2006 | EP1151102B1 Glycosylated leptin compositions and related methods |
| 04/19/2006 | EP1103561B1 Hla-a2 restraint tumor antigen peptide originating in sart-1 |
| 04/19/2006 | EP0912733B1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
| 04/19/2006 | EP0912608B1 Choline binding proteins for anti-pneumococcal vaccines |
| 04/19/2006 | EP0789574B1 Use of naked polynucleotides in the manufacture of a medicament for treating tumours |
| 04/19/2006 | EP0776370B1 Human erythropoietin receptor fragment and antibodies thereto |
| 04/19/2006 | EP0742821B1 Method for preparing a multicombinatorial library of antibody gene expression vectors |
| 04/19/2006 | CN1761754A Expression in plants of antibodies against enterotoxigenic escherichia coli |